A new research agenda to accelerate malaria elimination and eradication

November 30, 2017, Barcelona Institute for Global Health (ISGlobal)
P. falciparum merozoites. Glasswork by L. Jerram. Credit: Malaria glasswork by Luke Jerram. Graphic Design by Rachel Papernick

More than 180 scientists, malaria programme leaders and policy makers from around the world have come together through a consultative process to update the research agenda for malaria elimination and eradication, first published in 2011. The outcome is a series of seven 'malERA Refresh' (malaria eradication research agenda) papers that have been published as a special collection in PLOS Medicine. The aim of this exercise, coordinated by the Malaria Eradication Scientific Alliance (MESA) with headquarters at the Barcelona Institute for Global Health (ISGlobal), was to define a forward-looking research and development agenda that will accelerate progress towards malaria elimination and global eradication.

A world free of malaria would present enormous benefits in terms of health, equity and economy. The WHO has set ambitious goals for reducing the burden of malaria, and 21 countries have been identified as having the potential to eliminate local transmission of malaria by 2020. However, there is no easy path to achieving a malaria-free world and there is a real need for innovation. MalERA Refresh sets out a research agenda to meet the challenges, achieve these goals and, in the long-term eradicate it globally.

"The value of malERA Refresh is that it focuses on problems that need to be solved, not only the technologies that could be developed" states MESA chair Dr. Regina Rabinovich (ISGlobal and Harvard T.H. Chan School of Public Health). "Transforming the mindset from implementation to problem solving is an essential task for the next generation of scientists and program implementers," she adds.

The key messages highlighted in the introductory paper of the malERA Refresh collection can be summarized as follows:

  • Since 2011 significant progress has been made in R&D, including support for large-scale testing of the first approved vaccine (RTS,S), non-pyrethroid insecticides in the pipeline, new genetic technologies to block parasite transmission by mosquitoes, and identification of markers of drug resistant parasites.
  • This progress however has been matched with significant challenges, such as the expansion of insecticide and drug resistance, knowledge gaps particularly when working in low disease transmission settings, and tools to prevent disease reintroduction. Concerning Plasmodium vivax malaria, the most common malaria outside Africa, more is known about its transmission biology and epidemiology but we still lack tools to tackle it. In addition, the continuous evolution of malaria parasites and vectors brings new challenges. An example is the reported rise of Plasmodium knowlesi infections in South-East Asia, as well as changes in mosquito biting and resting habits.
  • Solutions to these problems require three types of innovation: 1) iterative innovation (for example, new medicines); 2) transformative innovation of tools and strategies to reduce or halt parasite transmission (for example, gene drive technologies); and 3) integrated approaches tailored to local contexts and local variations in disease transmission dynamics.

To update the agenda, six panels with over 180 experts from different disciplines and countries engaged in a collaborative process to address progress made and main challenges in the following areas: basic science and technologies; insecticide and drug resistance; characterising the reservoir and measuring transmission; diagnostics, drugs, vaccines and vector control; combination interventions and modelling; and health systems and policy research.

"A critical recognition of the malERA Refresh is that eradication efforts perturb the ecological balance of . This changing landscape requires ongoing research to understand the impact of this perturbation, and the resulting need to change tactics. This iterative process is the core of the malERA Refresh effort," says Professor Dyann Wirth (Harvard T.H. Chan School of Public Health).

Each panel was guided by a chair and co-chair(s) who are renowned experts in their respective fields. The whole process was overseen by a Leadership Group composed of Drs. Regina Rabinovich (ISGlobal and Harvard T.H. Chan School of Public Health), Pedro Alonso (WHO Global Malaria Programme), Marcel Tanner (Swiss Tropical and Public Health Institute) and Dyann Wirth (Harvard T.H. Chan School of Public Health).

Dr. Rabinovich warns that in order to pursue the opportunities proposed in the agenda, a diverse landscape of funders is needed, as well as "a continuous monitoring of research, its impact and the emergence of new challenges to keep the community on course."

For Professor Marcel Tanner (Swiss TPH), "MalERA-refresh will give new momentum to science in the public and private sectors and particularly the key R&D efforts that will make elimination possible."

The malERA Refresh collection is considered a complement to the WHO 'Global Technical Strategy for Malaria' (GTS) and the Roll Back Malaria 'Action and Investment to defeat Malaria' (AIM). Pedro Alonso, Director of the WHO Global Malaria Programme, underlined the importance of the updated agenda as a key pathfinder for the Global Observatory on Health R&D and added: "Robust research is critical for the WHO to build evidence-based policies and guidelines."

Explore further: Should we commit to eradicate malaria worldwide?

More information: collections.plos.org/malera-refresh

Rabinovich RN, Drakeley C, Djimde AA, Hall BF, Hay SI, Hemingway J, et al. (2017) malERA: An updated research agenda for malaria elimination and eradication. PLoS Med 14(11): e1002456. doi.org/10.1371/journal.pmed.1002456

Related Stories

Should we commit to eradicate malaria worldwide?

March 3, 2017
For Bruno Moonen, Deputy Director for malaria at the Global Health Program, eradication is the only equitable and sustainable solution.

Superbug's spread to Vietnam threatens malaria control

September 21, 2017
A highly drug resistant malaria 'superbug' from western Cambodia is now present in southern Vietnam, leading to alarming failure rates for dihydroartemisinin (DHA)-piperaquine—Vietnam's national first-line malaria treatment, ...

Eliminating malaria has longlasting benefits for many countries

February 21, 2013
Many nations battling malaria face an economic dilemma: spend money indefinitely to control malaria transmission or commit additional resources to eliminate transmission completely.

Hormone-disrupting compound could provide new approach to malaria control

December 15, 2016
A chemical that disrupts biological processes in female mosquitoes may be just as effective as insecticides in reducing the spread of malaria, according to a new study from Harvard T.H. Chan School of Public Health.

Recommended for you

How long is an Ebola survivor contagious? One case is causing scientists to rethink the answer.

August 14, 2018
Surviving Ebola isn't like getting over the flu.

Study shows how MERS coronavirus evolves to infect different species

August 14, 2018
In the past 15 years, two outbreaks of severe respiratory disease were caused by coronaviruses transmitted from animals to humans. In 2003, SARS-CoV (severe acute respiratory syndrome coronavirus) spread from civets to infect ...

Inching closer to a soft spot in isoniazid-resistant tuberculosis

August 14, 2018
Antibiotic-resistant tuberculosis is a public health threat. TB and other bacteria become resistant to antibiotics by evolving genetic changes over time, which they can do quite quickly because bacterial lifecycles are short. ...

Why do women get more migraines?

August 14, 2018
Research published today reveals a potential mechanism for migraine causation which could explain why women get more migraines than men. The study, in Frontiers in Molecular Biosciences, suggests that sex hormones affect ...

Link between common 'harmless' virus and cardiovascular damage

August 13, 2018
Researchers from Brighton and Sussex Medical School (BSMS) have found an unexpectedly close link between a herpes virus and the occurrence of immune cells damaging cardiovascular tissue.

Rotavirus vaccine cuts infant diarrhoea deaths by a third in Malawi

August 11, 2018
A major new study has shown that rotavirus vaccination reduced infant diarrhoea deaths by 34% in rural Malawi, a region with high levels of child deaths.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.